Immediate Impact

4 by Nobel laureates 8 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

One‐Step Symbiosis of Bimetallic Peroxides Nanoparticles to Induce Ferroptosis/Cuproptosis and Activate cGAS‐STING Pathway for Enhanced Tumor Immunotherapy
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
1 intermediate paper

Works of Sylvia Herter being referenced

Antitumour activity of the glycoengineered type II anti‐CD20 antibody obinutuzumab (GA101) in combination with the MDM2‐selective antagonist idasanutlin (RG7388)
2016
GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab
2012

Author Peers

Author Last Decade Papers Cites
Sylvia Herter 338 361 141 326 34 739
Dongmei Fan 134 348 132 172 49 711
Frank Herting 193 229 177 163 28 700
Silvia Mele 182 291 68 203 21 655
Sven Berger 351 318 60 247 25 724
Ekkehard Moessner 225 256 53 243 20 600
Claire A. Walshe 356 178 221 296 17 811
Brian J. Sworder 86 222 134 238 33 680
Gary Mason 164 305 143 107 32 698
James D. Owens 159 160 114 305 27 839
David Woo 322 246 96 82 35 728

All Works

Loading papers...

Rankless by CCL
2026